---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-030531"
form_type: "8-K"
ticker: "COYA"
cik: "0001835022"
company_name: "Coya Therapeutics, Inc."
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T06:04:25.673587+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Coya Therapeutics raises $11.1M via private placement with Dr. Reddy's and Greenlight Capital

## Summary
- Gross proceeds of ~$11.1M from sale of 2,522,727 shares at $4.40 each; no broker/agent.
- Dr. Reddy's Labs invests $10M, Greenlight Capital $1.1M; expected close Jan 30, 2026.
- Proceeds to accelerate tech transfer and scale-up manufacturing for low dose IL-2 to support COYA 302.
- Reiterates cash runway into H2 2027 and past projected ALSTARS trial topline.

## SEC filing metadata
- accession: 0001193125-26-030531
- form_type: 8-K
- ticker: COYA
- cik: 0001835022
- company_name: Coya Therapeutics, Inc.
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/0001193125-26-030531-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/d88735d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-030531
- JSON: https://secwatch.observer/filing/0001193125-26-030531.json
- Plain text: https://secwatch.observer/filing/0001193125-26-030531.txt

## Key facts
- Material Agreements
  Coya Therapeutics, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $11.1 million (effective 2026-01-29).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: approximately $11.1 million
  - Effective: 2026-01-29
  source text: On January 29, 2026, Coya Therapeutics, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Securities Purchase Agreement ”) with certain accredited investors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/0001193125-26-030531-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.